1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Infertility Treatment Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Sperm Separation Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovum Aspiration Pumps
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Sperm Analyzer Systems
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Micromanipulator Systems
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Incubators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Cryosystems
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Imaging Systems
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Microscopes
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Others
6.9.1 Market Trends
6.9.2 Market Forecast
7 Market Breakup by Patient Type
7.1 Female Infertility Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Male Infertility Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Fertility Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals and Other Healthcare Facilities
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ab Scientific Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Cook Group Incorporated
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Coopersurgical Inc. (The Cooper Companies Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Eppendorf
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Esco Micro Pte. Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Genea Limited
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Hamilton Throne Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Kitazato Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Rocket Medical plc
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thomas Medical (Medgyn Products Inc.)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Vitrolife
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer